Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
Open accessThe DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations to PKD1 or PKD2, triggering progressive cystogenesis and typically leading to end-stage renal disease in midlife. The phenotypic spectrum, however, ranges from in utero onset to adequate renal function at old age. Recent patient data suggest that the disease is dosage dependent, where incompletely penetrant alleles influence disease severity. Here, we have developed a knockin mouse model matching a likely disease variant, PKD1 p.R3277C (RC), and have proved that its functionally hypomorphic nature modifies the ADPKD phenotype. While Pkd1+/null mice are normal, Pkd1RC/null mice have rapidly progressive disease, and Pkd1RC/RC animals develop gradual cystogenesis. These models effectively mimic the pathophysiological features of in utero-onset and typical ADPKD, respectively, correlating the level of functional Pkd1 product with disease severity, highlighting the dosage dependence of cystogenesis. Additionally, molecular analyses identified p.R3277C as a temperature-sensitive folding/trafficking mutant, and length defects in collecting duct primary cilia, the organelle central to PKD pathogenesis, were clearly detected for the first time to our knowledge in PKD1. Altogether, this study highlights the role that in trans variants at the disease locus can play in phenotypic modification of dominant diseases and provides a truly orthologous PKD1 model, optimal for therapeutic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies revealed that mutations in Prksch or Sec63 greatly reduce the expression, stability and proper trafficking of polycystin-1 (PC1), leading to cyst formation in a dose-dependent manner [426,427].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [427]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and proteomic profiling of exosomes in human urine
Pisitkun, T., Shen, R.-F., & Knepper, M. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403453101 · Cited by 2,174 · cited 2×
“21, 22).”
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells
Nauli, S. M., Alenghat, F. J., Luo, Y., Williams, E., Vassilev, P., Li, X., Elia, A. E. H., Lu, W., Brown, E. M., Quinn, S. J., et al. (2003) · Nature Genetics · doi:10.1038/ng1076 · Cited by 2,057 · cited 2×
“However, in PKD1, the majority of studies have not detected cilia length defects, but the data are not conclusive, as these studies were largely conducted by light microscopy using cultured cells (14, 15, 80, 81).”
Autosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Self-citationPKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein
Mochizuki, T., Wu, G., Hayashi, T., Xenophontos, S. L., Veldhuisen, B., Saris, J. J., Reynolds, D. M., Cai, Y., Gabow, P. A., Pierides, A., et al. (1996) · Science · doi:10.1126/science.272.5266.1339 · Cited by 1,406 · cited 1×
“3) and PKD2 (4q21), mutated in approximately 85% and 15% of cases, respectively (3–5).”
Hildebrandt, F., Benzing, T., & Katsanis, N. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1010172 · Cited by 1,331
A Highly Efficient Recombineering-Based Method for Generating Conditional Knockout Mutations
Liu, P., Jenkins, N. A., & Copeland, N. G. (2003) · Genome Research · doi:10.1101/gr.749203 · Cited by 1,013 · cited 1×
“A β -lactamase expression cassette flanked with a 3 ′ Sal I site was recom-bineered into IVS30, using the DY380 E. coli strain (63).”
Yoder, B. K., Hou, X., & Guay-Woodford, L. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000029587.47950.25 · Cited by 935
Hughes, J., Ward, C. J., Peral, B., Aspinwall, R., Clark, K., San Millán, J. L., Gamble, V., & Harris, P. C. (1995) · Nature Genetics · doi:10.1038/ng0695-151 · Cited by 910 · cited 1×
“82, 83).”
Self-citationDise, T. E. P. K. (1994) · Cell · doi:10.1016/0092-8674(94)90137-6 · Cited by 903
Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents
Hanaoka, K., Qian, F., Boletta, A., Bhunia, A. K., Piontek, K., Tsiokas, L., Sukhatme, V. P., Guggino, W. B., & Germino, G. G. (2000) · Nature · doi:10.1038/35050128 · Cited by 818 · cited 1×
“One possibility is that the PC complex acts as a mechanosensor, signaling via a Ca 2+ influx through PC-2, a TRP channel, after fluid flow detection by PC-1 (14, 16, 20).”
Volume Progression in Polycystic Kidney Disease
Grantham, J. J., Torres, V. E., Chapman, A. B., Guay-Woodford, L. M., Bae, K. T., King, B. F., Wetzel, L. H., Baumgarten, D. A., Kenney, P. J., Harris, P. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054341 · Cited by 807 · cited 1×
“Our 60%-reduction model (Pkd1RC/RC) appears to best mimic human ADPKD (over a shorter timescale) with a 9-month progressive expansion and then a slight reduction in KV associated with fibrosis as ESRD approaches (101).”
Self-citationGattone, V. H., Wang, X., Harris, P. C., & Torres, V. E. (2003) · Nature Medicine · doi:10.1038/nm935 · Cited by 670
Self-citationPKD1 interacts with PKD2 through a probable coiled-coil domain
Qian, F., Germino, F. J., Cai, Y., Zhang, X., Somlo, S., & Germino, G. G. (1997) · Nature Genetics · doi:10.1038/ng0697-179 · Cited by 661
Variability in gene expression underlies incomplete penetrance
Raj, A., Rifkin, S. A., Andersen, E., & van Oudenaarden, A. (2010) · Nature · doi:10.1038/nature08781 · Cited by 636
Comparison of phenotypes of polycystic kidney disease types 1 and 2
Hateboer, N., v Dijk, M. A., Bogdanova, N., Coto, E., Saggar-Malik, A. K., Millan, J. L. S., Torra, R., Breuning, M., & Ravine, D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03495-3 · Cited by 628 · cited 1×
“org Volume 122 Number 11 November 2012 The severity of disease in ADPKD has been directly associated with the gene mutated; PKD1 on average leads to ESRD at approximately 54 years, while PKD2 leads to ESRD at approximately 74 years (42).”
Qian, F., Watnick, T. J., Onuchic, L. F., & Germino, G. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81793-6 · Cited by 615
Autosomal dominant polycystic kidney disease: the last 3 years
Torres, V. E., & Harris, P. C. (2009) · Kidney International · doi:10.1038/ki.2009.128 · Cited by 590 · cited 6×
“…appear to maintain the structural integrity of the cilia or regulate protein trafficking to and from the organelle, while the PKD1 and PKD2 proteins, polycystin-1 (PC-1) and polycystin-2 (PC-2), respectively, are thought to form a complex on the primary cilium and act as a receptor (14, 16–19).”
InfluentialSelf-citationSomatic Inactivation of Pkd2 Results in Polycystic Kidney Disease
Wu, G., D'Agati, V., Cai, Y., Markowitz, G., Park, J. H., Reynolds, D. M., Maeda, Y., Le, T. C., Hou, H., Kucherlapati, R., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81570-6 · Cited by 570 · cited 1×
“Analysis of ELVs collected from Pkd2 WS25/– mice that have a similar level of cystogenesis as the analyzed Pkd1 RC/RC mice showed unaltered levels of PC-1 NTP** compared with WT mice, highlighting that the reduction in PC-1 in the Pkd1 RC/RC mice is not due to the presence of cystic disease (57).”
Pazour, G. J., San Agustin, J. T., Follit, J. A., Rosenbaum, J. L., & Witman, G. B. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00877-1 · Cited by 531 · cited 1×
“…appear to maintain the structural integrity of the cilia or regulate protein trafficking to and from the organelle, while the PKD1 and PKD2 proteins, polycystin-1 (PC-1) and polycystin-2 (PC-2), respectively, are thought to form a complex on the primary cilium and act as a receptor (14, 16–19).”
Brook-Carter, P. T., Peral, B., Ward, C. J., Thompson, P., Hughes, J., Maheshwar, M. M., Nellist, M., Gamble, V., Harris, P. C., & Sampson, J. R. (1994) · Nature Genetics · doi:10.1038/ng1294-328 · Cited by 510 · cited 2×
“…and a HNF1B or PKHD1 allele, highlighting the fact that digenic inheritance may account for some of the phenotypic variability seen in ADPKD (45–47 , 62 Insights from our model systems into the etiology of in utero ADPKD and the functional analysis of the mutant PC-1 provide further clues to…”
Self-citationEffective treatment of an orthologous model of autosomal dominant polycystic kidney disease
Torres, V. E., Wang, X., Qian, Q., Somlo, S., Harris, P. C., & Gattone, V. H. (2004) · Nature Medicine · doi:10.1038/nm1004 · Cited by 482 · cited 2×
“The observation that the majority of adult cysts are of CD origin correlates with the AVPR2 antagonists showing some benefit in ADPKD (31, 32, 78).”
Self-citationPerinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation
Lu, W., Peissel, B., Babakhanlou, H., Pavlova, A., Geng, L., Fan, X., Larson, C., Brent, G., & Zhou, J. (1997) · Nature Genetics · doi:10.1038/ng1097-179 · Cited by 451 · cited 1×
“5 (33, 35, 51).”
Comprehensive Molecular Diagnostics in Autosomal Dominant Polycystic Kidney Disease
Rossetti, S., Consugar, M. B., Chapman, A. B., Torres, V. E., Guay-Woodford, L. M., Grantham, J. J., Bennett, W. M., Meyers, C. M., Walker, D. L., Bae, K., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121387 · Cited by 439
Self-citationDalgaard, O. Z. (1957) · PubMed · Cited by 426
A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1
Piontek, K., Menezes, L. F., Garcia-Gonzalez, M. A., Huso, D. L., & Germino, G. G. (2007) · Nature Medicine · doi:10.1038/nm1675 · Cited by 425 · cited 4×
“…kidney tissue from P18 Pkd1 RC/del2 mice, indicating increased proliferation in noncystic and cystic CDs (DBA) compared with that in WT. Reports on associations between cyst expansion and proliferation are controversial, but analysis of the CD showed a clear increase in cell division (36, 37, 79).”
InfluentialVariability in gene expression underlies incomplete penetrance
van Oudenaarden, A., Rifkin, S. A., Raj, A., & Andersen, E. C. (2010) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 424
Epidemiology of Adult Polycystic Kidney Disease, Olmsted County, Minnesota: 1935–1980
Garcia Iglesias, C., Torres, V. E., Offord, K. P., Holley, K. E., Beard, C. M., & Kurland, L. T. (1983) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(83)80044-4 · Cited by 384 · cited 1×
“173900 for PKD1 and 613095 for PKD2]) is one of the most common monogenic disorders, with a prevalence of 1:400 to 1:1,000 (1, 2).”
Self-citationRenal Cystic Disease in Tuberous Sclerosis: Role of the Polycystic Kidney Disease 1 Gene
Sampson, J. R., Maheshwar, M. M., Aspinwall, R., Thompson, P., Cheadle, J. P., Ravine, D., Roy, S., Haan, E., Bernstein, J., & Harris, P. C. (1997) · The American Journal of Human Genetics · doi:10.1086/514888 · Cited by 373
Self-citationYamaguchi, T., Wallace, D. P., Magenheimer, B. S., Hempson, S. J., Grantham, J. J., & Calvet, J. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405079200 · Cited by 353 · cited 2×
“These defects include, but are not limited to, dedifferentiation, increased proliferation and apoptosis, polarity defects, and altered gene expression that may be linked to increased intracellular cAMP, possibly associated with decreased intracellular Ca 2+ (16, 27).”
Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease
Leeuwen, I. S. L.-V., Dauwerse, J. G., Baelde, H. J., Leonhard, W. N., van de Wal, A., Ward, C. J., Verbeek, S., DeRuiter, M. C., Breuning, M. H., de Heer, E., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh336 · Cited by 352 · cited 4×
“gressive cystic disease in the kidney, liver, and pancreas, despite the presence of some functional polycystin (40, 41, 58).”
InfluentialSelf-citationPolycystin-1 and -2 Dosage Regulates Pressure Sensing
Sharif-Naeini, R., Folgering, J. H. A., Bichet, D., Duprat, F., Lauritzen, I., Arhatte, M., Jodar, M., Dedman, A., Chatelain, F. C., Schulte, U., et al. (2009) · Cell · doi:10.1016/j.cell.2009.08.045 · Cited by 345 · cited 1×
“However, the localization and function of PC-1 and PC-2 are still controversial, and various alternative cilia-related roles have been proposed (16, 23–26).”
Identification of Signaling Pathways Regulating Primary Cilium Length and Flow-Mediated Adaptation
Besschetnova, T. Y., Kolpakova-Hart, E., Guan, Y., Zhou, J., Olsen, B. R., & Shah, J. V. (2010) · Current Biology · doi:10.1016/j.cub.2009.11.072 · Cited by 334 · cited 2×
“…cAMP levels and injury/inflammation, the latter of which may be associated with the observed increase in cilia length within the microhamartoma; however, within the kidney, it is of interest that we observed the length increase independent of the cystogenic state of the tubule (80, 99, 100).”
Characterization of PKD Protein-Positive Exosome-Like Vesicles
Hogan, M. C., Manganelli, L., Woollard, J. R., Masyuk, A. I., Masyuk, T. V., Tammachote, R., Huang, B. Q., Leontovich, A. A., Beito, T. G., Madden, B. J., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060564 · Cited by 333 · cited 3×
“Additionally, urinary exosomelike vesicles (ELVs), which contain high levels of the polycystins, have been suggested to play a role in the mediation of signaling events at the primary cilia (11, 21, 22).”
Self-citationQian, F., Boletta, A., Bhunia, A. K., Xu, H., Liu, L., Ahrabi, A. K., Watnick, T. J., Zhou, F., & Germino, G. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252484899 · Cited by 329 · cited 4×
“82, 83).”
InfluentialBae, K. T., Zhu, F., Chapman, A. B., Torres, V. E., Grantham, J. J., Guay-Woodford, L. M., Baumgarten, D. A., King, B. F., Wetzel, L. H., Kenney, P. J., et al. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00080605 · Cited by 312 · cited 2×
“These cystic lesions are progenitors of the liver cysts often found in patients with ADPKD (69).”
Self-citationCardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene
Boulter, C., Mulroy, S., Webb, S., Fleming, S., Brindle, K., & Sandford, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211191098 · Cited by 309 · cited 1×
“(A) Pkd1 animals develop a osteopenia like phenotype characterized by a significant decrease in cortical (left μCT image + graph) and trabecular (right μCT image) bone mass – a phenotype known to be associated with a reduction of Pkd1 in mice(1, 2).”
Rossetti, S., Kubly, V. J., Consugar, M. B., Hopp, K., Roy, S., Horsley, S. W., Chauveau, D., Rees, L., Barratt, T. M., van't Hoff, W. G., et al. (2009) · Kidney International · doi:10.1038/ki.2008.686 · Cited by 300 · cited 10×
“An amplified 129/Sv Pkd1 fragment, spanning from the Ahd I site (IVS27) to the end of the β -lactamase cassette ( Xho I; IVS30), was cloned into the shuttle vector, and Pkd1 p.R3277C was introduced using the Phusion Site-Directed Mutagenesis Kit (NEB) (29, 59).”
InfluentialSelf-citationMechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases
Torres, V. E., & Harris, P. C. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0070 · Cited by 296 · cited 4×
“This is consistent with PT cysts predom-inating in early-onset ADPKD cases, with a similar shift from PT to CD cysts associated with completion of kidney development in ARPKD (28, 29, 39, 76, 77).”
InfluentialSelf-citationVasopressin Directly Regulates Cyst Growth in Polycystic Kidney Disease
Wang, X., Wu, Y., Ward, C. J., Harris, P. C., & Torres, V. E. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060688 · Cited by 286
Self-citationHarris, P. C., Bae, K. T., Rossetti, S., Torres, V. E., Grantham, J. J., Chapman, A. B., Guay-Woodford, L. M., King, B. F., Wetzel, L. H., Baumgarten, D. A., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080835 · Cited by 271 · cited 1×
“Previous comparisons of PKD1 and PKD2 concluded that it was the rate of cyst initiation rather than rate of expansion that makes PKD1 more severe (88).”
Self-citationZode, G. S., Kuehn, M. H., Nishimura, D. Y., Searby, C. C., Mohan, K., Grozdanic, S. D., Bugge, K., Anderson, M. G., Clark, A. F., Stone, E. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58183 · Cited by 268 · cited 1×
“This indicates that, in addition to the current experimental therapies that focus on cAMP and other signaling defects, chaperone-enhancing or proteasome-inhibiting strategies may also be effective in a subset of patients with missense mutations to PKD1 or PKD2 (102, 103).”
Fedeles, S. V., Tian, X., Gallagher, A.-R., Mitobe, M., Nishio, S., Lee, S. H., Cai, Y., Geng, L., Crews, C. M., & Somlo, S. (2011) · Nature Genetics · doi:10.1038/ng.860 · Cited by 262 · cited 10×
“3) and PKD2 (4q21), mutated in approximately 85% and 15% of cases, respectively (3–5).”
InfluentialBrasier, J. L., & Henske, E. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119147 · Cited by 260 · cited 2×
“Although, there is strong evidence of a second-hit mechanism, with detected somatic mutations in large cysts, we propose that they are not necessary for cyst initiation and instead may play a role in cyst progression by providing cysts a growth or survival advantage (53–56).”
Zode, G. S., Kuehn, M. H., Nishimura, D. Y., Searby, C. C., Mohan, K., Grozdanic, S. D., Bugge, K., Anderson, M. G., Clark, A. F., Stone, E. M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82799 · Cited by 260
Mutations in Multiple PKD Genes May Explain Early and Severe Polycystic Kidney Disease
Bergmann, C., von Bothmer, J., Ortiz Brüchle, N., Venghaus, A., Frank, V., Fehrenbach, H., Hampel, T., Pape, L., Buske, A., Jonsson, J., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101080 · Cited by 238 · cited 3×
“…families, highlighting other possible incompletely penetrant alleles, indicate a broader applicability, but studies of larger populations and better definition of these alleles are needed to determine the full importance of in trans inheritance to explaining early-onset disease (29, 59–62).”
Lantinga-van Leeuwen, I. S., Leonhard, W. N., van der Wal, A., Breuning, M. H., de Heer, E., & Peters, D. J. M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm299 · Cited by 223 · cited 2×
“The role of proliferation to cyst expansion in ADPKD is a controversial one, but when analysis is limited to tubular/cystic epithelia, increased cell division clearly occurs (36, 37, 79).”
Rossetti, S., & Harris, P. C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010125 · Cited by 217
Self-citationMasyuk, T. V., Huang, B. Q., Ward, C. J., Masyuk, A. I., Yuan, D., Splinter, P. L., Punyashthiti, R., Ritman, E. L., Torres, V. E., Harris, P. C., et al. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.09.001 · Cited by 209
Self-citationNewby, L. J., Streets, A. J., Zhao, Y., Harris, P. C., Ward, C. J., & Ong, A. C. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107788200 · Cited by 204 · cited 1×
“It has also been reported that endogenous PC-1 is observed as 2 distinct glycoforms, endogly-cosidase H–resistant (EndoH-resistant) (NTP**) and -sensitive (NTP*) forms (84).”
Self-citationSmith, L. A., Bukanov, N. O., Husson, H., Russo, R. J., Barry, T. C., Taylor, A. L., Beier, D. R., & Ibraghimov-Beskrovnaya, O. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006020136 · Cited by 200
Role of N-glycosylation in trafficking of apical membrane proteins in epithelia
Vagin, O., Kraut, J. A., & Sachs, G. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90340.2008 · Cited by 198 · cited 1×
“…a difference in protein trafficking of these glycoforms, as EndoH resistance is obtained in the trans-Golgi, in which high-mannose oligosaccharides are converted to complex saccharides by the addition of N-acetylglucosamine to form secreted or membrane-bound, mature, forms of the protein (85).”
PEI, Y., WATNICK, T., HE, N., WANG, K., LIANG, Y., PARFREY, P., GERMINO, G., & GEORGE-HYSLOP, P. S. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1071524 · Cited by 192
BILATERAL POLYCYSTIC DISEASE OF THE KIDNEYS
DALGAARD, O. Z. (1959) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195904000-00016 · Cited by 181
Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Chapman, A. B., Johnson, A. M., Rainguet, S., Hossack, K., Gabow, P., & Schrier, R. W. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v881292 · Cited by 180
Mazzaccara, C., Labruna, G., Cito, G., Scarfò, M., Felice, M. D., Pastore, L., & Sacchetti, L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003772 · Cited by 173
Fibrosis and progression of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Norman, J. T. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.012 · Cited by 167 · cited 1×
“org Volume 122 Number 11 November 2012 proinflammatory and profibrotic mediators, epithelial production of extracellular matrix proteins, and epithelial-mesenchymal transition, likely promote the fibrosis (65).”
Bilineal Disease and Trans-Heterozygotes in Autosomal Dominant Polycystic Kidney Disease
Pei, Y., Paterson, A. D., Wang, K. R., He, N., Hefferton, D., Watnick, T., Germino, G. G., Parfrey, P., Somlo, S., & St. George-Hyslop, P. (2001) · The American Journal of Human Genetics · doi:10.1086/318188 · Cited by 163 · cited 1×
“Causes of extreme intrafamilial phenotypic variation include mosaicism or bilineal inheritance of a pathogenic PKD1 and PKD2 variant, but these do not account for the majority of cases with extreme ADPKD phenotypes (45, 48, 49).”
Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes
Lu, W., Fan, X., Basora, N., Babakhanlou, H., Law, T., Rifai, N., Harris, P. C., Perez-Atayde, A. R., Rennke, H. G., & Zhou, J. (1999) · Nature Genetics · doi:10.1038/5944 · Cited by 160 · cited 1×
“These cystic lesions have been reported previously in Pkd1+/null animals, are characteristic of human ADPKD, and are the progenitors of the liver cysts found in the majority of patients (34, 69).”
Self-citationTolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience
Higashihara, E., Torres, V. E., Chapman, A. B., Grantham, J. J., Bae, K. T., Watnick, T. J., Horie, S., Nutahara, K., Ouyang, J., Krasa, H. B., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03530411 · Cited by 152 · cited 3×
“The observation that the majority of adult cysts are of CD origin correlates with the AVPR2 antagonists showing some benefit in ADPKD (31, 32, 78).”
Self-citationPioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant
Muto, S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.15.1731 · Cited by 152 · cited 4×
“51, 59).”
InfluentialXu, C. Q., Rossetti, S., Jiang, L., Harris, P. C., Brown-Glaberman, U., Wandinger‐Ness, A., Bacallao, R. L., & Alper, S. L. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00285.2006 · Cited by 151 · cited 1×
“However, no clear ciliary structural abnormalities have been described in PKD1 (13–15).”
Self-citationBaert, L. V. (1978) · Kidney International · doi:10.1038/ki.1978.75 · Cited by 148 · cited 2×
“Traditionally, all tubule segments have been thought to be involved in disease, but the available data are limited and somewhat contradictory (28–30).”
Incompletely Penetrant PKD1 Alleles Mimic the Renal Manifestations of ARPKD
Vujic, M., Heyer, C. M., Ars, E., Hopp, K., Markoff, A., Örndal, C., Rudenhed, B., Nasr, S. H., Torres, V. E., Torrá, R., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009101070 · Cited by 148 · cited 9×
“An amplified 129/Sv Pkd1 fragment, spanning from the Ahd I site (IVS27) to the end of the β -lactamase cassette ( Xho I; IVS30), was cloned into the shuttle vector, and Pkd1 p.R3277C was introduced using the Phusion Site-Directed Mutagenesis Kit (NEB) (29, 59).”
InfluentialSelf-citationConsugar, M. B., Wong, W. C., Lundquist, P. A., Rossetti, S., Kubly, V. J., Walker, D. L., Rangel, L. J., Aspinwall, R., Niaudet, W. P., Özen, S., et al. (2008) · Kidney International · doi:10.1038/ki.2008.485 · Cited by 144 · cited 1×
“but these do not account for the majority of cases with extreme ADPKD phenotypes (45, 48, 49).”
Self-citationPrimary cilia elongation in response to interleukin-1 mediates the inflammatory response
Wann, A. K. T., & Knight, M. M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0980-y · Cited by 139 · cited 1×
“…cAMP levels and injury/inflammation, the latter of which may be associated with the observed increase in cilia length within the microhamartoma; however, within the kidney, it is of interest that we observed the length increase independent of the cystogenic state of the tubule (80, 99, 100).”
Tammachote, R., Sieben, C. J., Sinders, R. M., Miller, C. A., Czarnecki, P. G., Leightner, A. C., Salisbury, J. L., Ward, C. J., Torres, V. E., Gattone, V. H., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp272 · Cited by 138
Self-citationNishio, S., Hatano, M., Nagata, M., Horie, S., Koike, T., Tokuhisa, T., & Mochizuki, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22850 · Cited by 134
Jiang, S., Chiou, Y., Wang, E., Lin, H.-K., Lin, Y.-T., Chi, Y.-C., Wang, C. L., Tang, M., & Li, H. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050342 · Cited by 132 · cited 4×
“Homozygous Pkd1 and Pkd2 hypomorphs, with 13% to 33% correctly spliced Pkd1 or Pkd2 , are viable but develop progressive cystic disease in the kidney, liver, and pancreas, despite the presence of some functional polycystin (40, 41, 58).”
InfluentialProliferative activity of intrinsic cell populations in the normal human kidney.
Nádasdy, T., Laszik, Z. G., Blick, K. E., Johnson, L. D., & Silva, F. G. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v4122032 · Cited by 125
PRENATAL DIAGNOSIS OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE WITH A DNA PROBE
Reeders, S. T., Gal, A., Propping, P., Waldherr, R., Davies, K. E., Zerres, K., Hogenkamp, T., Schmidt, W. K., Dolata, M. M., & Weatherall, D. J. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92557-2 · Cited by 120 · cited 1×
“59, 70).”
Woollard, J. R., Punyashtiti, R., Richardson, S., Masyuk, T. V., Whelan, S. L., Huang, B. Q., Lager, D. J., vanDeursen, J., Torres, V. E., Gattone, V. H., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002294 · Cited by 119 · cited 3×
“Additionally, urinary exosomelike vesicles (ELVs), which contain high levels of the polycystins, have been suggested to play a role in the mediation of signaling events at the primary cilia (11, 21, 22).”
Self-citationKoptides, M., Hadjimichael, C., Koupepidou, P., Pierides, A., & Deltas, C. C. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.509 · Cited by 118
Pkd1 Inactivation Induced in Adulthood Produces Focal Cystic Disease
Takakura, A., Contrino, L., Beck, A. W., & Zhou, J. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101139 · Cited by 117 · cited 1×
“…in progressive cystic disease, and PKD severity in conditional ADPKD mice differs radically depending on the age at complete polycystin inactivation (36–38 Although the cellular recessive mechanism is attractive, recent data indicate that the dosage level of the polycystins may be important.”
Zerres, K., Rudnik‐Schöneborn, S., & Deget, F. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.7.583 · Cited by 116 · cited 3×
“from rare in utero–onset cases to patients with adequate renal function in old age; extreme heterogeneity that cannot be solely explained by genic effects (6, 43, 44).”
Bastos, A. P., Piontek, K., da Silva, A. M. G., Martini, D., Menezes, L. F., da Fonseca, J. M., Fonseca, I. I., Germino, G. G., & Onuchic², L. F. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008040435 · Cited by 108 · cited 1×
“…factors, such as variation in the PC-1 expression level from cell to cell and so-called third hits (perhaps to be considered second hits now), such as renal damage or other factors triggering proliferation, may be key to driving a cell or segment of tubule into cystic transformation (96–98).”
Nims, N. M., Vassmer, D., & Maser, R. L. (2003) · Biochemistry · doi:10.1021/bi035074c · Cited by 103
Verghese, E., Weidenfeld, R., Bertram, J. F., Ricardo, S. D., & Deane, J. A. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm743 · Cited by 102 · cited 1×
“…cAMP levels and injury/inflammation, the latter of which may be associated with the observed increase in cilia length within the microhamartoma; however, within the kidney, it is of interest that we observed the length increase independent of the cystogenic state of the tubule (80, 99, 100).”
Polycystic Kidney Disease, Autosomal Dominant
(2011) · Springer eBooks · doi:10.1007/springerreference_33714 · Cited by 95
Chemical and Biological Folding Contribute to Temperature‐Sensitive ΔF508 CFTR Trafficking
Wang, X., Koulov, A. V., Kellner, W. A., Riordan, J. R., & Balch, W. E. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00806.x · Cited by 91
Loss of polycystin-1 causes centrosome amplification and genomic instability
Battini, L., Macip, S., Fedorova, E., DIKMAN, S. H., Somlo, S., Montagna, C., & Gusella, G. L. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn180 · Cited by 91 · cited 1×
“However, the localization and function of PC-1 and PC-2 are still controversial, and various alternative cilia-related roles have been proposed (16, 23–26).”
Starremans, P. G. J. F., Li, X., Finnerty, P. E., Guo, L., Takakura, A., Neilson, E. G., & Zhou, J. (2008) · Kidney International · doi:10.1038/ki.2008.111 · Cited by 89 · cited 2×
“This is consistent with PT cysts predom-inating in early-onset ADPKD cases, with a similar shift from PT to CD cysts associated with completion of kidney development in ARPKD (28, 29, 39, 76, 77).”
Chapter 6 Mouse Models of Polycystic Kidney Disease
Wilson, P. D. (2008) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(08)00606-6 · Cited by 88
Xu, C. Q., Shmukler, B. E., Nishimura, K. K., Kaczmarek, E., Rossetti, S., Harris, P. C., Wandinger‐Ness, A., Bacallao, R. L., & Alper, S. L. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90542.2008 · Cited by 86 · cited 1×
“However, in PKD1, the majority of studies have not detected cilia length defects, but the data are not conclusive, as these studies were largely conducted by light microscopy using cultured cells (14, 15, 80, 81).”
Self-citationPkd1 transgenic mice: adult model of polycystic kidney disease with extrarenal and renal phenotypes
Kurbegovic, A., Côté, O., Couillard, M., Ward, C. J., Harris, P. C., & Trudel, M. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp588 · Cited by 85 · cited 3×
“However, no clear ciliary structural abnormalities have been described in PKD1 (13–15).”
Self-citationKim, I., Li, C., Liang, D., Chen, X., Coffy, R. J., Ma, J., Zhao, P., & Wu, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805452200 · Cited by 83 · cited 1×
“Homozygous Pkd1 and Pkd2 hypomorphs, with 13% to 33% correctly spliced Pkd1 or Pkd2 , are viable but develop progressive cystic disease in the kidney, liver, and pancreas, despite the presence of some functional polycystin (40, 41, 58).”
Evidence of Extraordinary Growth in the Progressive Enlargement of Renal Cysts
Grantham, J. J., Cook, L. T., Wetzel, L. H., Cadnapaphornchai, M. A., & Bae, K. T. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00550110 · Cited by 78 · cited 1×
“Understanding this switch is important, since theoretical considerations have highlighted that embryonic cysts, by growing at faster rates compared with cysts initiated later in life, contribute majorly to the total cyst burden (95).”
Zhang, W., Zhu, J. J., Efferson, C. L., Ware, C., Tammam, J. G., Angagaw, M. H., Laskey, J., Bettano, K. A., Kasibhatla, S., Reilly, J. F., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4385 · Cited by 78 · cited 1×
“12 months was performed as described previously (106) with the follow-”
Epitope-Tagged Pkhd1 Tracks the Processing, Secretion, and Localization of Fibrocystin
Bakeberg, J. L., Tammachote, R., Woollard, J. R., Hogan, M. C., Tuan, H.-F., Li, M., van Deursen, J. M., Wu, Y., Huang, B. Q., Torres, V. E., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111173 · Cited by 78 · cited 2×
“ELVs were isolated as described previously (104).”
Self-citationProximal Tubular Cysts in Fetal Human Autosomal Recessive Polycystic Kidney Disease
Nakanishi, K., Sweeney, W. E., Zerres, K., Guay‐Woodford, L. M., & Avner, E. D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v114760 · Cited by 77
Xiao, Z., Zhang, S., Cao, L., Qiu, N., David, V., & Quarles, L. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.050906 · Cited by 74 · cited 1×
“RT analysis of osteocalcin, Runx2 , and Gapdh was performed as previously described (71).”
Association of PKD2 (Polycystin 2) Mutations With Left-Right Laterality Defects
Bataille, S., Demoulin, N., Devuyst, O., Audrézet, M., Dahan, K., Godin, M., Fontés, M., Pirson, Y., & Burtey, S. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.05.015 · Cited by 67
Cystic diseases of the kidney: ciliary dysfunction and cystogenic mechanisms
Gascue, C., Katsanis, N., & Badano, J. L. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1697-5 · Cited by 65 · cited 1×
“For example, cyst development has been strongly associated with defects to the primary cilia, as evident from model systems and syndromic PKD forms, categorizing PKD as a ciliopathy (8, 9).”
A missense mutation in PKD1 attenuates the severity of renal disease
Pei, Y., Lan, Z., Wang, K., García-González, M. Á., He, N., Dicks, E. L., Parfrey, P. S., Germino, G. G., & Watnick, T. J. (2011) · Kidney International · doi:10.1038/ki.2011.370 · Cited by 65
Genetic Variation of DKK3 May Modify Renal Disease Severity in ADPKD
Liu, X., Shi, S. Y., Senthilnathan, S., Yu, J. L., Wu, E., Bergmann, C., Zerres, K., Bogdanova, N., Coto, E., Deltas, C. C., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010030237 · Cited by 63
Self-citationWhat Is the Role of Somatic Mutation in Autosomal Dominant Polycystic Kidney Disease?
Harris, P. C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010030328 · Cited by 56 · cited 2×
“A major argument for the 2-hit hypothesis is that the cyst development in ADPKD is focal, each the result of an individual somatic mutation (50).”
Self-citationPaterson, A. D., Wang, K. R., Lupea, D., George‐Hyslop, P. S., & Pei, Y. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33908 · Cited by 48 · cited 1×
“Likewise, the corresponding human genotype is thought to be incompatible with life (52).”
Pereira, R., Halford, K. W., Sokolov, B. P., Khillan, J. S., & Prockop, D. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117161 · Cited by 48
Losekoot, M., Ruivenkamp, C. A. L., Tholens, A., Grimbergen, J., Vijfhuizen, L., Vermeer, S., Dijkman, H. B. P. M., Cornelissen, E. A. M., Bongers, E. M. H. F., & Peters, D. J. M. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100452 · Cited by 48 · cited 1×
“Emerging family data suggested that in trans inheritance of a null and an incompletely penetrant PKD1 allele could result in the devastating early-onset phenotype (29, 59–61).”
Connor, A., Lunt, P. W., Dolling, C., Patel, Y., Meredith, A. L., Gardner, A., Hamilton, N., & Dudley, C. R. K. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02030.x · Cited by 45 · cited 1×
“Causes of extreme intrafamilial phenotypic variation include mosaicism or bilineal inheritance of a pathogenic PKD1 and PKD2 variant, but these do not account for the majority of cases with extreme ADPKD phenotypes (45, 48, 49).”
Stroope, A. J., Radtke, B. N., Huang, B. Q., Masyuk, T. V., Torres, V. E., Ritman, E. L., & LaRusso, N. F. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090658 · Cited by 39 · cited 4×
“The role of proliferation to cyst expansion in ADPKD is a controversial one, but when analysis is limited to tubular/cystic epithelia, increased cell division clearly occurs (36, 37, 79).”
InfluentialSelf-citationPerinatal Deaths in a Family with Autosomal Dominant Polycystic Kidney Disease and aPKD2Mutation
Bergmann, C., Brüchle, N. O., Frank, V., Rehder, H., & Zerres, K. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0801868 · Cited by 38 · cited 2×
“In this study, we set out to understand the etiology and patho-mechanism associated with the phenotypic heterogeneity of PKD1, which at its extremes ranges from mild PKD in old age without renal insufficiency to in utero lethality (6, 43, 44).”
Steigelman, K. A., Lelli, A., Wu, X., Gao, J., Lin, S., Piontek, K., Wodarczyk, C., Boletta, A., Kim, H., Qian, F., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6531-10.2011 · Cited by 34 · cited 1×
“org Volume 122 Number 11 November 2012 2007;16(24):3188–3196.”
Wang, E., Hsieh-Li, H.-M., Chiou, Y., Chien, Y., Ho, H., Chin, H.-J. G., Wang, C. L., Liang, S., & Jiang, S. (2010) · The Journal of Pathology · doi:10.1002/path.2765 · Cited by 34 · cited 1×
“The progressive PKD associated with transgenic miRNA reduction of Pkd1 by 60% to 70% is consistent with the dosage model presented here (90).”
Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion
Ahrabi, A. K., Jouret, F., Marbaix, É., Delporte, C., Horie, S., Mulroy, S., Boulter, C. A., Sandford, R. N., & Devuyst, O. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp611 · Cited by 33 · cited 1×
“This is consistent with PT cysts predom-inating in early-onset ADPKD cases, with a similar shift from PT to CD cysts associated with completion of kidney development in ARPKD (28, 29, 39, 76, 77).”
Li, D., Yu, J., Gu, F., Pang, X., Ma, X., Li, R., Liu, N., & Ma, X. (2008) · Genetic Testing · doi:10.1089/gte.2008.0002 · Cited by 25 · cited 1×
“Further, it seems likely that this pathomechanism is important to the phenotypic variability of other haploinsufficient, dominant diseases, although the large array of “normal” variants cataloged at PKD1 indicate that it may be an extreme example (PKDB, http://pkdb.mayo.edu) (91, 92).”
Lectin Peroxidase Conjugate Reactivity in Acquired Cystic Disease of the Kidney
Ishikawa, I., Horiguchi, T., & Shikura, N. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000185287 · Cited by 14 · cited 1×
“The PT dilatation at this stage may reflect acquired renal cystic disease associated with advanced renal insufficiency as seen in human ADPKD (74, 75).”
Volume Changes in Autosomal Dominant Polycystic Kidneys after the Initiation of Hemodialysis
Ishikawa, I., & Saito, Y. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000187586 · Cited by 12 · cited 1×
“A similar decrease in %KW/BW associated with increased fibrosis has been observed at earlier ages in other hypomorphic Pkd1 models and in late stages of human ADPKD (40, 41, 64).”
Tissue-specific Expression and Splicing of the Rat Polycystic Kidney Disease 1 Gene
Xu, H., Shen, J., Walker, C. L., & Kleymenova, E. (2001) · DNA sequence · doi:10.3109/10425170109084460 · Cited by 11 · cited 1×
“A normally seen alternative splice product, skipping exon 31 (in-frame change), was not significantly different between WT and homozygous animals (asterisk) (105) (PCR product, 762 bp; splice variant, 669 bp).”
Cell Proliferation in the Developing Human Kidney
Nádasdy, T., Lajoie, G., Laszik, Z. G., Blick, K. E., Nadasdy, G. M., & Silva, F. G. (1998) · Pediatric and Developmental Pathology · doi:10.1007/s100249900006 · Cited by 10 · cited 2×
“The proliferation of immature early tubules (S-shaped bodies) is very high and remains high throughout embryonic life (93).”
Acquired Cystic Disease of the Kidney Analyzed by Microdissection
Vandeursen, H., Damme, B. V., Baert, J. H., & Baert, L. V. (1991) · The Journal of Urology · doi:10.1016/s0022-5347(17)38033-3 · Cited by 9 · cited 1×
“The PT dilatation at this stage may reflect acquired renal cystic disease associated with advanced renal insufficiency as seen in human ADPKD (74, 75).”
A Combined SEM and TEM Study on the Basal Labyrinth of the Collecting Duct in the Rat Kidney.
Fukudome, H. (2001) · Archivum histologicum japonicum · doi:10.1679/aohc.64.339 · Cited by 7 · cited 1×
“CDs were identified based on known morphological features, and bile ducts were identified based on their proximity to a portal vein/hepatic artery (107).”
(1824) · The Lancet · doi:10.1016/s0140-6736(02)83545-0 · Cited by 3
Research works printed but not linked: 1
- Dalgaard, 1957, Acta Med Scand Suppl., 328, 1
Cited by
Bergmann, C., Guay-Woodford, L. M., Harris, P. C., Horie, S., Peters, D. J. M., & Torres, V. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0047-y · Cited by 807
Self-citationAutosomal dominant polycystic kidney disease
Cornec-Le Gall, E., Alam, A., & Perrone, R. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32782-x · Cited by 624
Type of PKD1 Mutation Influences Renal Outcome in ADPKD
Cornec-Le Gall, E., Audrézet, M.-P., Chen, J.-M., Hourmant, M., Morin, M.-P., Perrichot, R., Charasse, C., Whebe, B., Renaudineau, E., Jousset, P., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012070650 · Cited by 530
Porath, B., Gainullin, V. G., Cornec-Le Gall, E., Dillinger, E. K., Heyer, C. M., Hopp, K., Edwards, M. E., Madsen, C. D., Mauritz, S. R., Banks, C. J., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.05.004 · Cited by 475
Self-citationGenetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases
Cornec-Le Gall, E., Torres, V. E., & Harris, P. C. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017050483 · Cited by 406
Self-citation
Metadata
- Authors
- Hopp, K., Ward, C. J., Hommerding, C. J., Nasr, S. H., Tuan, H.-F., Gainullin, V. G., Rossetti, S., Torres, V. E., & Harris, P. C.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Harris, Peter C.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-15
- Volume
- 122
- Issue
- 11
- Pages
- 4257-4273
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3484456
- OpenAlex
- W2085346322
- Cited by
- 442
- References
- 112
- Citations by year
- 2026: 34 · 2025: 34 · 2024: 45 · 2023: 43 · 2022: 44 · 2021: 44 · 2020: 38 · 2019: 23 · 2018: 19 · 2017: 20 · 2016: 21 · 2015: 31 · 2014: 26 · 2013: 18
- FWCI
- 14.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic (DK090728)
- American Heart Association
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-058816, DK090728, R01DK044863, P30DK090728, R01DK058816)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- autosomal dominant polycystic kidney disease, polycystin-1, PKD1, hypomorphic allele, dosage dependence, disease severity, cyst formation, knockin mouse model, primary cilia, collecting duct, temperature-sensitive mutants, phenotypic variability
- MeSH terms
- Animals, Disease Models, Animal, Severity of Illness Index, Polycystic Kidney, Autosomal Dominant, Protein Folding, Amino Acid Substitution, Mutation, Missense, Animals, Genetically Modified, TRPP Cation Channels, Mice, Gene Knock-In Techniques, Genetic Loci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.